Cadrus has
secured rights from the University of Massachusetts Medical School to a patent
pending technology for trapping drugs in the GPs.The Company plans to file patents on further
developments of this trapping technology including improvements and specific
applications for small molecule, peptide and protein drugs.Additionally Cadrus will develop and patent
alternative approaches to formulate drugs into the GP particle system and plans
to identify and in-license complementary technology.
Cadrus Therapeutics, Inc. 67 Millbrook Street Suite 422 Worcester, MA 01606